EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Endometrial metabolism of 17β-estradiol during the window of implantation in women with recurrent implantation failure

Linda B P M Stevens Brentjens, Bert Delvoux, Janneke E den Hartog, Darina Obukhova, Sofia Xanthoulea, Andrea Romano, Ron J T van Golde

Gynecologic and Obstetric Investigation · 2025

DOI: 10.1159/000546442 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Gynecologic and Obstetric Investigation, 2025. Verfasst von Linda B P M Stevens Brentjens und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Maastricht University Medical Centre+, Maastricht, The Netherlands, linda.brentjens@mumc.nl. Hauptthemen laut MEDLINE: Endometrium, Estradiol, Embryo Implantation, 17-Hydroxysteroid Dehydrogenases. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Alterations in 17β-estradiol metabolism are known to potentially impair endometrial receptivity. Previous pioneering studies have investigated the role of endometrial steroid metabolism by determining steroid hormone levels and steroid-metabolizing enzyme activity in endometrial biopsies of patients undergoing IVF. The activity of oxidative and reductive 17β-hydroxysteroid dehydrogenases (17β-HSDs), which catalyse the interconversion between estrone and 17β-estradiol, was found to be similar between IVF patients who - after fresh embryo transfer in the cycle following endometrial biopsy - did and did not become pregnant. However, inhibition of the reductive enzyme 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1), the most prominent 17β-HSD type in 17β-estradiol formation, was found to differ between groups. The primary objective of this study is to determine oxidative and reductive 17β-HSD enzyme activity in the endometrium of two well-defined groups: IVF patients with Recurrent Implantation Failure (RIF) and control patients.

Design

Prospective observational study of IVF patients with RIF (n=52) and controls (n=25). Patients undergoing treatment because of pre-implantation genetic testing, a severe male factor or bilateral tubal pathology were recruited as controls, since these conditions did not suggest an endometrial contribution to infertility. Participants/Materials, Setting, Methods Endometrial biopsies were obtained 5 to 8 days after a positive urine ovulation test in a natural cycle using a Pipelle catheter. Activity of oxidative and reductive enzymes, inhibition of 17β-HSD1, 5, 7 and 12 and immunostaining of 17β-HSD7 were performed. The formation of 17β-estradiol by reduction of estrone (reductive enzymes), formation of estrone by oxidation of 17β-estradiol (oxidative enzymes) and inhibition of specific 17β-HSD enzymes was determined using high performance liquid chromatography. Formalin fixed paraffin embedded tissue was used for immunostaining. The Student’s t-test and Mann-Whitney U test were used for statistical analysis. Multivariate analysis was used to determine the influence of confounders.

Results

No differences were found in activity of oxidative and reductive 17β-HSD enzymes in RIF patients and controls. Combined inhibition of 17β-HSD5, 7 and 12 was significantly lower in the RIF group compared to controls (p=0.04). Inhibition of 17β-HSD1 and 17β-HSD7 combined was also significantly lower (more production of 17β-estradiol remained) in the RIF group compared to controls (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriumEstradiolEmbryo Implantation17-Hydroxysteroid DehydrogenasesHumansFemaleAdultFertilization in VitroProspective StudiesPregnancyEmbryo TransferTreatment Failure

Stichwörter der Autor:innen

17β-EstradiolEndometriumImplantationIn vitro fertilizationIntracrinology

Substanzen

Estradiol17-Hydroxysteroid Dehydrogenases

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Maastricht University Medical Centre+, Maastricht, The Netherlands, linda.brentjens@mumc.nl.
  • GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands, linda.brentjens@mumc.nl.
  • Department of Obstetrics and Gynaecology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  • GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Zitieren

APA

Stevens Brentjens, L. B. P. M., Delvoux, B., den Hartog, J. E., Obukhova, D., Xanthoulea, S., Romano, A., & van Golde, R. J. T. (2025). Endometrial metabolism of 17β-estradiol during the window of implantation in women with recurrent implantation failure. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000546442

Vancouver

Stevens Brentjens LBPM, Delvoux B, den Hartog JE, Obukhova D, Xanthoulea S, Romano A, et al. Endometrial metabolism of 17β-estradiol during the window of implantation in women with recurrent implantation failure. Gynecologic and Obstetric Investigation. 2025. doi:10.1159/000546442

BibTeX
@article{StevensBrentjens2025,
  author = {Stevens Brentjens, Linda B P M and Delvoux, Bert and den Hartog, Janneke E and Obukhova, Darina and Xanthoulea, Sofia and Romano, Andrea and van Golde, Ron J T},
  title = {Endometrial metabolism of 17β-estradiol during the window of implantation in women with recurrent implantation failure},
  journal = {Gynecologic and Obstetric Investigation},
  year = {2025},
  doi = {10.1159/000546442}
}
Kostenlos starten →